Real-time enrollment status for this myelofibrosis clinical trial
Current Status
Unknown
Checked: June 2, 2026 at 2:16 AM UTC
| NCT Number | NCT04655118 |
| Recruiting Status | Unknown |
| Condition | Myelofibrosis |
| Phase | Clinical Trial |
| Target Enrollment | 121 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Telios Pharma, Inc. |
| Last Updated on CT.gov | May 10, 2024 (May 10, 2024) |
As of June 2, 2026: Clinical trial NCT04655118 is currently unknown participants. This clinical trial study for myelofibrosis is not currently accepting new participants at 6 locations across the United States. The study is sponsored by Telios Pharma, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT04655118 is currently unknown. The study may resume recruiting in the future.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04655118 was last updated May 10, 2024 (May 10, 2024). HelloStudys verifies this status automatically.